Funding · Company
Biolinq Inc
San Diego, CABiotech & Pharma
Biolinq Inc of San Diego, CA has disclosed $227M across 3 Form D offerings filed with the SEC between Jun 1, 2022 and Mar 21, 2025.
$227M
Total disclosed
3
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$90M
Form D · Mar 21, 2025 ↗
Q1 2025
· target $100M
$59M
Form D · Sep 13, 2024 ↗
Q3 2024
· 2 amendments, first filed Dec 26, 2023
$78M
Form D · Jun 1, 2022 ↗
Q2 2022
· 1 amendment, first filed Sep 17, 2021
· target $106M
Filing details
HeadquartersSan Diego, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001685406Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →